Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-12-02T19:54:26.005Z Has data issue: false hasContentIssue false
  • English
  • Français

Cost of Antimicrobial Therapy Across US Children’s Hospitals

Published online by Cambridge University Press:  13 July 2015

Rachael K. Ross ,
Adam L. Hersh ,
Matthew P. Kronman ,
Jason G. Newland  and
Jeffrey S. Gerber
Rachael K. Ross
Affiliation:
Division of Infectious Diseases and Center for Pediatric Clinical Effectiveness, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
Adam L. Hersh
Affiliation:
Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah, Salt Lake City, Utah
Matthew P. Kronman
Affiliation:
Division of Infectious Diseases, Seattle Children’s Hospital, Seattle, Washington
Jason G. Newland
Affiliation:
Division of Infectious Diseases, Children’s Mercy Hospitals and Clinics, Kansas City, Kansas
Jeffrey S. Gerber*
Affiliation:
Division of Infectious Diseases and Center for Pediatric Clinical Effectiveness, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania
*
Address correspondence to Jeffrey S. Gerber, MD, PhD, Division of Infectious Diseases, Children’s Hospital of Philadelphia, CHOP North, Ste 1518, Philadelphia, PA 19104 ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

We analyzed the cost of antimicrobial prescribing across freestanding children’s hospitals. A few specific antimicrobials accounted for a large proportion of expenditures, and antimicrobial spending varied substantially across hospitals, even within specific clinical conditions. Antimicrobial stewardship programs should consider these data to incorporate high-value antimicrobial prescribing when clinically appropriate.

Infect Control Hosp Epidemiol 2015;36(10):1242–1244

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 36 , Issue 10 , October 2015 , pp. 1242 - 1244
Copyright
© 2015 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Presented in part: ID Week 2014; Philadelphia, Pennsylvania.

References

REFERENCES

1. Schumock, GT, Li, EC, Suda, KJ, et al. National trends in prescription drug expenditures and projections for 2014. Am J Health Syst Pharm 2014;71:482–499.CrossRefGoogle ScholarPubMed
2. Hoffman, JM, Doloresco, F, Vermeulen, LC, et al. Projecting future drug expenditures—2010. Am J Health Syst Pharm 2010;67:919–928.Google Scholar
3. Gerber, JS, Newland, JG, Coffin, SE, et al. Variability in antibiotic use at children's hospitals. Pediatrics 2010;126:1067–1073.Google Scholar
4. Gerber, JS, Kronman, MP, Ross, RK, et al. Identifying targets for antimicrobial stewardship in children's hospitals. Infect Control Hosp Epidemiol 2013;34:1252–1258.CrossRefGoogle ScholarPubMed
5. Hersh, AL, De Lurgio, SA, Thurm, C, et al. Antimicrobial stewardship programs in freestanding children's hospitals. Pediatrics 2015;135:33–39.CrossRefGoogle ScholarPubMed
6. Di Pentima, MC, Chan, S, Hossain, J. Benefits of a pediatric antimicrobial stewardship program at a children's hospital. Pediatrics 2011;128:1062–1070.Google Scholar
7. Metjian, TA, Prasad, PA, Kogon, A, Coffin, SE, Zaoutis, TE. Evaluation of an antimicrobial stewardship program at a pediatric teaching hospital. Pediatr Infect Dis J 2008;27:106–111.CrossRefGoogle Scholar
8. Suda, KJ, Hicks, LA, Roberts, RM, Hunkler, RJ, Danziger, LH. A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009. J Antimicrob Chemother 2013;68:715–718.Google Scholar
9. Averill, RF, Goldfield, N, Hughes, JS, et al. All Patient Refined Diagnosis Related Groups (APR-DRGs), Version 20.0: Methodology Overview. Wallingford, CT: 3M Health Information Systems, 2003.Google Scholar
10. Feudtner, C, Christakis, DA, Connell, FA. Pediatric deaths attributable to complex chronic conditions: a population-based study of Washington State, 1980-1997. Pediatrics 2000;106:205–209.Google Scholar
11. Hoffman, JM, Shah, ND, Vermeulen, LC, et al. Projecting future drug expenditures—2008. Am J Health Syst Pharm 2008;65:234–253.CrossRefGoogle ScholarPubMed